Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 55 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Difelikefalin for pruritus associated with chronic kidney disease	Difelikefalin (Korsuva; CR845)	Pruritus	Cardiovascular System , Dermatology , Nephrology	2020	View \| Download
Deucravacitinib for treating active psoriatic arthritis	Deucravacitinib (BMS-986165)	Psoriatic arthritis	Dermatology , Rheumatology	2023	View \| Download
Dersimelagon for previously untreated erythropoietic protoporphyria and X-linked protoporphyria	Dersimelagon	Erythropoietic protoporphyria , X-linked protoporphyria	Dermatology , Haematology	2022	View \| Download
Delgocitinib for treating moderate to severe chronic hand eczema after 1 previous therapy	Delgocitinib	Chronic hand eczema	Dermatology	2023	View \| Download
Certolizumab pegol (Cimzia) for chronic plaque psoriasis in adults	Certolizumab (CDP-870; Cimzia; certolizumab pegol)	Plaque psoriasis	Dermatology	2017	View \| Download
BMS-986165 for moderate to severe plaque psoriasis	Deucravacitinib (BMS-986165)	Plaque psoriasis	Dermatology	2020	View \| Download
Bimekizumab for moderate to severe chronic plaque psoriasis	Bimekizumab (UCB4940)	Plaque psoriasis	Dermatology	2019	View \| Download
Bimekizumab for Hidradenitis Suppurativa	Bimekizumab (UCB4940)	Hidradenitis suppurativa (HS)	Dermatology	2022	View \| Download
Bimekizumab for active psoriatic arthritis	Bimekizumab (UCB4940)	Psoriatic arthritis	Dermatology , Rheumatology	2021	View \| Download
Beremagene geperpavec for dystrophic epidermolysis bullosa	Bercolagene telserpavec (Beremagene geperpavec; KB103)	Dystrophic epidermolysis bullosa (DEB)	Dermatology	2021	View \| Download